⚠️💊 Long COVID and ME/CFS: a layered strategy, not a single treatment for everyone One of the mistakes when talking about Long COVID and ME/CFS is looking for “the treatment”, as if all patients had exactly the same mechanism. They do not. But that does not mean there is no common logic. The model I propose is to think of these diseases as post-infectious processes maintained by layers: A persistent pathogen or a sustained antigenic source. Chronic immune hyperactivation. Immune exhaustion and poorer control of latent pathogens. Secondary reactivations that add more antigenic load. Systemic consequences: inflammation, mast cells/histamine, oxidative stress, barrier dysfunction, autoimmunity, dysautonomia, neuroinflammation, endocrine alterations or vascular involvement. Baseline treatments and then treatments directed according to the dominant mechanism. The key is not to place all layers at the same level. Not everything is a primary cause. Some things are consequences. And some consequences, once they appear, can become amplifiers that maintain the vicious cycle. Long COVID and ME/CFS: same model, different degree of classification For me, Long COVID and ME/CFS are not opposite processes. They may follow the same post-infectious model. The main difference is that Long COVID is better classified by its initial pathogen: SARS-CoV-2. By contrast, ME/CFS is a more heterogeneous label where post-infectious patients initiated or maintained by different pathogens may be grouped together: EBV, HHV-6, CMV, enteroviruses, parvovirus B19, Borrelia, Toxoplasma or other persistent, latent or intracellular pathogens. In other words: Long COVID would be a post-infectious disease defined by SARS-CoV-2. ME/CFS could include several similar post-infectious subtypes, but initiated by different pathogens. The underlying logic would be the same: persistent pathogen or antigenic reservoir → continuous immune stimulation → chronic immune hyperactivation → sustained inflammation → T/NK cell exhaustion → poorer control of latent pathogens → new reactivations → more antigenic load → more inflammation. Therefore, the problem would not be that Long COVID and ME/CFS have nothing to do with each other. The problem is that ME/CFS probably mixes post-infectious patients of different origins under the same clinical label. ▪️Long COVID: SARS-CoV-2 as the initial persistent source In Long COVID, the initial axis would be the persistence of SARS-CoV-2 in tissue or cellular reservoirs, with sustained or intermittent production of viral antigens. There does not necessarily have to be detectable viremia in blood. But if the immune system keeps seeing viral antigens months or years later, those antigens are not well explained as simple passive “remnants” from the initial infection. The body degrades proteins and RNA through proteases, nucleases, autophagy, the proteasome, cellular turnover and immune clearance. For this reason, prolonged presence of viral antigen points to a sustained source: tissue reservoirs; infected cells; low-level persistent infection; abortive or incomplete infection; intermittent production of viral material; local reactivation; or cellular persistence in tissues where the immune system does not properly eliminate the stimulus. In other words: if there is persistent antigen for months or years, we need to think of some type of reservoir or biological source that renews it. That stimulus keeps the immune system chronically activated. And that chronic activation can lead to persistent inflammation, immune exhaustion and poorer control of other latent pathogens.